Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay

Overview on guidelines and recommendations for generic low-molecular-weight heparins

(2011) Job Harenberg   THROMBOSIS RESEARCH

FDA approves first generic enoxaparin product

(2010) C. A. Thompson   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Heparin-Induced Thrombocytopenia

(2010) Gowthami M. Arepally et al.   Annual Review of Medicine

Effects on Molecular Conformation and Anticoagulant Activities of 1,6-Anhydrosugars at the Reducing Terminal of Antithrombin-Binding Octasaccharides Isolated from Low-Molecular-Weight Heparin Enoxaparin

(2010) Marco Guerrini et al.   JOURNAL OF MEDICINAL CHEMISTRY

Fondaparinux: does it cause HIT? can it treat HIT?

(2010) Theodore E Warkentin   Expert Review of Hematology

Antithrombin-binding Octasaccharides and Role of Extensions of the Active Pentasaccharide Sequence in the Specificity and Strength of Interaction

(2008) Marco Guerrini et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Differentiating Low-Molecular-Weight Heparins Based on Chemical, Biological, and Pharmacologic Properties: Implications for the Development of Generic Versions of Low-Molecular-Weight Heparins

(2008) Walter Jeske et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS